Pernix Therapeutics, Inc. Reports First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2013.
Financial Results
For the first quarter of 2013, net revenues increased by approximately 52% to $22.1 million, compared to $14.5 million for the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NASDAQ: PTX), a specialty pharmaceutical company, today announced financial results for the quarter ended March 31, 2013.
Financial Results
For the first quarter of 2013, net revenues increased by approximately 52% to $22.1 million, compared to $14.5 million for the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.